封面
市场调查报告书
商品编码
1477249

血糖监测市场,按类型、按组件、按最终用户、按地理位置

Blood Glucose Monitoring Market, By Type, By Component, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球血糖监测市场价值为188.5亿美元,预计到2031年将达到371.4亿美元,2024年至2031年年复合成长率(CAGR)为10.2%。

报告范围 报告详情
基准年: 2023年 2024 年市场规模: 188.5 亿美元
历史数据: 2019年至2023年 预测期: 2024年至2031年
预测 2024 年至 2031 年复合年增长率: 10.20% 2031 年价值预测: 371.4 亿美元
图 1. 2024 年血糖监测市场占有率 (%)(按地区)
血糖监测市场 - IMG1

血糖监测对于管理糖尿病至关重要,因为它可以帮助患者监测血糖水平并定期采取纠正措施。自我监测设备的便利性和可负担性,以及人们对糖尿病照护意识的不断提高,推动了血糖监测解决方案在全球范围内得到更广泛的采用。此外,技术进步导致创新监控设备的开发,这些设备具有增强的准确性、便利性和连接性,预计将在未来几年进一步推动市场成长。

市场动态:

由于全球糖尿病人口不断增加以及人们对糖尿病管理的日益关注,全球血糖监测市场一直在稳步增长。肥胖和久坐生活方式日益普遍等多种因素正在加剧全球糖尿病负担,这反过来又推动了血糖监测设备的采用。此外,用户友好且负担得起的监测解决方案的开发以及已开发地区有利的报销政策正在鼓励更多地采用自我监测设备。然而,与先进血糖监测仪相关的高成本仍然是一个主要挑战,特别是在发展中国家。此外,网路威胁和资料外洩的漏洞可能会阻碍向连网监控设备的过渡。儘管如此,持续的技术升级,包括微创连续血糖监测系统的开发,为市场参与者带来了光明的前景。

研究的主要特点:

  • 该报告对全球血糖监测市场进行了深入分析,并提供了以2023年为基准年的预测期(2024-2031)的市场规模(十亿美元)和年复合成长率(CAGR%)。
  • 它阐明了不同细分市场的潜在收入成长机会,并解释了该市场有吸引力的投资主张矩阵。
  • 这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
  • 它根据以下参数描述了全球血糖监测市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
  • 该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球血糖监测市场迎合了该行业的各个利益相关者,包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
  • 利害关係人可以透过用于分析全球血糖监测市场的各种策略矩阵轻鬆做出决策。

目录

第一章:研究目标与假设

  • 研究目标
  • 假设
  • 缩写

第 2 章:市场范围

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map (COM)

第 3 章:市场动态、法规与趋势分析

  • 市场动态
    • 司机
    • 限制
    • 机会
  • 影响分析
  • 市场走向
  • 最近的发展
  • 监管场景
  • 技术进步
  • 製造商收入
  • 收购和合作场景
  • 产品发布/批准
  • 资金和投资
  • PEST分析
  • 波特的分析

第 4 章:全球血糖监测市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第 5 章:2019 - 2031 年全球血糖监测市场(按类型)(十亿美元)

  • 概述
  • 自我监测血糖设备
  • 连续血糖监测装置
  • 快速血糖监测设备

第 6 章:2019 - 2031 年全球血糖监测市场(按组成部分)(十亿美元)

  • 概述
  • 血糖仪设备
  • 试纸条
  • 柳叶刀
  • 感应器
  • 其他的

第 7 章:全球血糖监测市场,按最终用户划分,2019 - 2031 年(十亿美元)

  • 概述
  • 医院
  • 家庭护理设置
  • 门诊护理设置
  • 其他的

第 8 章:2019 - 2031 年全球血糖监测市场(按地区)(十亿美元)

  • 介绍
  • 北美洲
  • 我们
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东协
  • 澳洲
  • 韩国
  • 亚太地区其他地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 中东其他地区
  • 非洲
  • 北非
  • 中非
  • 南非

第 9 章:竞争格局

  • 公司简介
    • Medtronic
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • B. Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • F. Hoffmann-La Roche Ltd.

第 10 章:分析师观点

  • 命运之轮
  • 分析师观点
  • 连贯的机会图

第 11 章:参考文献与研究方法

  • 参考
  • 研究方法论
简介目录
Product Code: CMI5382

The global blood glucose monitoring market is estimated to be valued at USD 18.85 Bn in 2024 and is expected to reach USD 37.14 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 18.85 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 10.20% 2031 Value Projection: US$ 37.14 Bn
Figure 1.Blood Glucose Monitoring Market Share (%), By Region, 2024
Blood Glucose Monitoring Market - IMG1

Blood glucose monitoring is crucial for managing diabetes as it helps patients monitor their blood sugar levels and take corrective measures on a regular basis. Easy availability and affordability of self-monitoring devices along with growing awareness about diabetes care have been driving the greater adoption of blood glucose monitoring solutions globally. In addition, technological advancements leading to the development of innovative monitoring devices with enhanced features for accuracy, convenience, and connectivity are expected to further propel the market growth in the coming years.

Market Dynamics:

The global blood glucose monitoring market has been witnessing steady growth attributed to rising diabetic population worldwide coupled with growing focus on diabetes management. Various factors, such as increasing prevalence of obesity and sedentary lifestyles, are contributing to the diabetes burden globally, which, in turn, is driving the adoption of blood glucose monitoring devices. Additionally, the development of user-friendly and affordable monitoring solutions along with favorable reimbursement policies in developed regions are encouraging the greater uptake of self-monitoring devices. However, high costs associated with advanced blood glucose monitors remains a key challenge, especially in developing countries. Moreover, vulnerabilities to cyber threats and data breaches could hamper the transition towards connected monitoring devices. Nonetheless, ongoing technological upgrades including the development of minimally invasive continuous glucose monitoring systems presents bright prospects for market players.

Key Features of the Study:

  • This report provides an in-depth analysis of the global blood glucose monitoring market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global blood glucose monitoring market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Medtronic, ACON Laboratories, Inc., Senseonics, Inc., Medisana AG, Bionime Corporation, AgaMatrix Inc., ARKRAY, Inc., Rossmax International Ltd., Dexcom, Inc., Nipro Group, B. Braun SE, Nova Biomedical, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, Nemaura, Terumo Corporation, and Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global blood glucose monitoring market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.

Detailed Segmentation-

  • By Type:
    • Self-monitoring blood glucose devices
    • Continuous glucose monitoring devices
    • Flash glucose monitoring devices
  • By Component:
    • Glucometer devices
    • Test strips
    • Lancets
    • Sensors
    • Others
  • By End User:
    • Hospitals
    • Homecare Settings
    • Ambulatory Care Settings
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Medtronic
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • Hoffmann-La Roche Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Component
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Technological Advancements
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Blood Glucose Monitoring Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Blood Glucose Monitoring Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Self-monitoring blood glucose devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Continuous glucose monitoring devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Flash glucose monitoring devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Blood Glucose Monitoring Market, By Component, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Glucometer devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Test strips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Lancets
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sensors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Blood Glucose Monitoring Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Homecare Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Ambulatory Care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Blood Glucose Monitoring Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Regions, 2020-2031
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profiles
    • Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • B. Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • F. Hoffmann-La Roche Ltd.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact